Immunocore

Immunocore

Immunocore

A world-leading biotechnologycompany with a highly innovative immune-oncology T cell receptor platform technology
Type
B2c
Founded
2008
Raised
$490M
Follow us
Alexa global traffic share
Twitter followers
Latest funding Show all
$130,000,000
Venture capital (Series B) - 2020
General Atlantic Rock Springs Capital CCB International +3
$40,000,000
Venture capital (Series B) - 2017
Bill & Melinda Gates Foundation
Team Size
50+
Employees
$130,000,000 Venture capital (Series B)
Pulse 2.0

Clinical-Stage T Cell Receptor Biotech Company Immunocore Raises Over $130 Million